Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980;10(Suppl 2):261S–278S. doi: 10.1111/j.1365-2125.1980.tb01809.x

Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors

A E Farah, F Rosenberg
PMCID: PMC1430184  PMID: 6776977

Abstract

1 The ubiquitous actions of the cyclo-oxygenase inhibitors are described.

2 These include the inhibitory effect on prostaglandin synthesis and the direct effect of aspirin on lymphocytes and their ability to produce lymphokines.

3 Aspirin reduces some types of platelet aggregation possibly involving inhibition of the precursors of thromboxane A2 and prostacyclin.

4 The therapeutic implications in relation to transient ischaemic attacks, coronary artery disease and reno-allograft rejection are discussed.

5 The beneficial and adverse effects on the gastro-intestinal tract are described.

6 The effects of aspirin-like drugs on the genito-urinary tract are described with particular reference to their adverse effects on labour and their therapeutic effect on dysmenorrhoea.

Full text

PDF
262S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addonizio V. P., Jr, Smith J. B., Guiod L. R., Strauss J. F., 3rd, Colman R. W., Edmunds L. H., Jr Thromboxane synthesis and platelet protein release during simulated extracorporeal circulation. Blood. 1979 Aug;54(2):371–376. [PubMed] [Google Scholar]
  2. Addonizio V. P., Jr, Strauss J. F., 3rd, Colman R. W., Edmunds L. H., Jr Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator. J Thorac Cardiovasc Surg. 1979 Jan;77(1):119–126. [PubMed] [Google Scholar]
  3. Addonizio V. P., Strauss J. F., Macarak E. J., Colman R. W., Edmunds H., Jr Preservation of platelet number and function with prostaglandin E1 during total cardiopulmonary bypass in rhesus monkeys. Surgery. 1978 Jun;83(6):619–625. [PubMed] [Google Scholar]
  4. Aiken J. W. Aspirin and indomethacin prolong parturition in rats: evidence that prostaglandins contribute to expulsion of fetus. Nature. 1972 Nov 3;240(5375):21–25. doi: 10.1038/240021a0. [DOI] [PubMed] [Google Scholar]
  5. Aiken J. W., Vane J. R. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther. 1973 Mar;184(3):678–687. [PubMed] [Google Scholar]
  6. Altman R., Boullon F., Rouvier J., Raca R., de la Fuente L., Favaloro R. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg. 1976 Jul;72(1):127–129. [PubMed] [Google Scholar]
  7. Ambrus J. L., Ambrus C. M., Gastpar H., Sapvento P. J., Weber F. J., Thurber L. E. Study of platelet aggregation in vivo i. Effect of bencyclan. J Med. 1976;7(6):439–447. [PubMed] [Google Scholar]
  8. Anderson A. B., Haynes P. J., Fraser I. S., Turnbull A. C. Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea. Lancet. 1978 Feb 18;1(8060):345–348. doi: 10.1016/s0140-6736(78)91077-2. [DOI] [PubMed] [Google Scholar]
  9. Anderson M., Dewar P., Fleming L. B., Hacking P. M., Morley A. R., Murray S., Swinney J., Taylor R. M., Uldall P. R., Wardle E. N. A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection. Clin Nephrol. 1974;2(3):93–99. [PubMed] [Google Scholar]
  10. Andrassy K., Ritz E., Schoeffner W., Hahn G., Walter K. The influence of acetylsalicylic acid on platelet adhesiveness and thrombotic fistula complications in hemodialysed patients. Klin Wochenschr. 1971 Feb;49(3):166–167. doi: 10.1007/BF01496814. [DOI] [PubMed] [Google Scholar]
  11. Anggård E., Larsson C., Weber P. Interactions between the renal prostaglandins and the renin--angiotensin system. Adv Prostaglandin Thromboxane Res. 1976;2:587–594. [PubMed] [Google Scholar]
  12. BARTTER F. C., PRONOVE P., GILL J. R., Jr, MACCARDLE R. C. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 1962 Dec;33:811–828. doi: 10.1016/0002-9343(62)90214-0. [DOI] [PubMed] [Google Scholar]
  13. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  14. BORN G. V., DAWES G. S., MOTT J. C., RENNICK B. R. The constriction of the ductus arteriosus caused by oxygen and by asphyxia in newborn lambs. J Physiol. 1956 May 28;132(2):304–342. doi: 10.1113/jphysiol.1956.sp005526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Barrowman J. A., Bennett A., Hillenbrand P., Rolles K., Pollock D. J., Wright J. T. Diarrhoeae in thyroid medullary carcinoma: role of prostaglandins and therapeutic effect of nutmeg. Br Med J. 1975 Jul 5;3(5974):11–12. doi: 10.1136/bmj.3.5974.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bartter F. C., Gill J. R., Jr, Frolich J. C. Bartter's syndrome. Adv Nephrol Necker Hosp. 1977;7:191–198. [PubMed] [Google Scholar]
  17. Baumgartner H. R., Tschopp T. B., Weiss H. J. Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium. Thromb Haemost. 1977 Feb 28;37(1):17–28. [PubMed] [Google Scholar]
  18. Baxter R. G., Larkins R. G., Martin F. I., Heyma P., Myles K., Ryan L. Down syndrome and thyroid function in adults. Lancet. 1975 Oct 25;2(7939):794–796. doi: 10.1016/s0140-6736(75)80007-9. [DOI] [PubMed] [Google Scholar]
  19. Behrman H. R., Anderson G. G. Prostaglandins in reproduction. Arch Intern Med. 1974 Jan;133(1):77–84. [PubMed] [Google Scholar]
  20. Behrman H. R., Orczyk G. P., Greep R. O. Effect of synthetic gonadotrophin-releasing hormone (Gn-RH) on ovulation blockade by aspirin and indomethacin. Prostaglandins. 1972 Apr;1(4):245–258. doi: 10.1016/s0090-6980(72)80001-7. [DOI] [PubMed] [Google Scholar]
  21. Bennett A., Gradidge C. F., Stamford I. F. Letter: Prostaglandins, nutmeg and diarrhea. N Engl J Med. 1974 Jan 10;290(2):110–111. doi: 10.1056/NEJM197401102900221. [DOI] [PubMed] [Google Scholar]
  22. Bennett A., Houghton J., Leaper D. J., Stamford I. F. Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen. Prostaglandins. 1979 Feb;17(2):179–191. doi: 10.1016/0090-6980(79)90037-6. [DOI] [PubMed] [Google Scholar]
  23. Bennett A., McDonald A. M., Simpson J. S., Stamford I. F. Breast cancer, prostaglandins, and bone metastases. Lancet. 1975 May 31;1(7918):1218–1220. doi: 10.1016/s0140-6736(75)92197-2. [DOI] [PubMed] [Google Scholar]
  24. Bennett A. Prostaglandins as factors in diseases of the alimentary tract. Adv Prostaglandin Thromboxane Res. 1976;2:547–555. [PubMed] [Google Scholar]
  25. Beurling-Harbury C., Galvan C. A. Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease. Blood. 1978 Jul;52(1):13–23. [PubMed] [Google Scholar]
  26. Bhattacherjee P., Eakins K. E. Inhibition of the prostaglandin synthetase systems in ocular tissues by indomethacin. Br J Pharmacol. 1974 Feb;50(2):227–230. doi: 10.1111/j.1476-5381.1974.tb08565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Blackwell G. J., Flower R. J., Vane J. R. Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomes. Biochim Biophys Acta. 1975 Jul 22;398(1):178–190. doi: 10.1016/0005-2760(75)90181-2. [DOI] [PubMed] [Google Scholar]
  28. Bonta I. L., Bult H., Vincent J. E., Zijlstra F. J. Acute anti-inflammatory effects of aspirin and dexamethasone in rats deprived of endogenous prostaglandin precursors. J Pharm Pharmacol. 1977 Jan;29(1):1–7. doi: 10.1111/j.2042-7158.1977.tb11227.x. [DOI] [PubMed] [Google Scholar]
  29. Bray M. A., Gordon D. Effects of anti-inflammatory drugs on macrophage prostaglandin biosynthesis [proceedings]. Br J Pharmacol. 1976 Jul;57(3):466P–467P. [PMC free article] [PubMed] [Google Scholar]
  30. Budoff P. W. Use of mefenamic acid in the treatment of primary dysmenorrhea. JAMA. 1979 Jun 22;241(25):2713–2716. [PubMed] [Google Scholar]
  31. Bygdeman M., Borell U., Leader A., Lundström V., Martin J. N., Jr, Eneroth P., Gréen K. Induction of first and second trimester abortion by the vaginal administration of 15-methyl-PGF2alpha methyl ester. Adv Prostaglandin Thromboxane Res. 1976;2:693–704. [PubMed] [Google Scholar]
  32. Cashin C. H., Dawson W., Kitchen E. A. The pharmacology of benoxaprofen (2-[4-chlorophenyl]-alpha-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J Pharm Pharmacol. 1977 Jun;29(6):330–336. doi: 10.1111/j.2042-7158.1977.tb11330.x. [DOI] [PubMed] [Google Scholar]
  33. Chan W. Y., Hill J. C. Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects. Prostaglandins. 1978 Feb;15(2):365–375. doi: 10.1016/0090-6980(78)90176-4. [DOI] [PubMed] [Google Scholar]
  34. Chapnick B. M., Paustian P. W., Klainer E., Joiner P. D., Hyman A. L., Kadowitz P. J. Influence of prostaglandins E, A and F on vasoconstrictor responses to norepinephrine, renal nerve stimulation and angiotensin in the feline kidney. J Pharmacol Exp Ther. 1976 Jan;196(1):44–52. [PubMed] [Google Scholar]
  35. Chaudhuri G., Elder M. G. Lack of evidence for inhibition of ovulation by aspirin in women. Prostaglandins. 1976 Apr;11(4):727–735. doi: 10.1016/0090-6980(76)90072-1. [DOI] [PubMed] [Google Scholar]
  36. Chester R., Dukes M., Slater S. R., Walpole A. L. Delay of parturition in the rat by anti-inflammatory agents which inhibit the biosynthesis of prostaglandins. Nature. 1972 Nov 3;240(5375):37–38. doi: 10.1038/240037a0. [DOI] [PubMed] [Google Scholar]
  37. Collier H. O. A pharmacological analysis of aspirin. Adv Pharmacol Chemother. 1969;7:333–405. [PubMed] [Google Scholar]
  38. Crout J. E., Hepburn B., Ritts R. E., Jr Suppression of lymphocyte transformation after aspirin ingestion. N Engl J Med. 1975 Jan 30;292(5):221–223. doi: 10.1056/NEJM197501302920501. [DOI] [PubMed] [Google Scholar]
  39. Csapo A. I. Prostaglandin impact. Adv Prostaglandin Thromboxane Res. 1976;2:705–718. [PubMed] [Google Scholar]
  40. De S., Sircar B. K., Sasmal D., De S. P., Mondal A. Ibuprofen (Brufen) in cholera and other diarrhoeas. Indian J Med Res. 1974 May;62(5):756–764. [PubMed] [Google Scholar]
  41. Dembinska-Kieĉ A., Zmuda A., Krupinska J. Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations. Adv Prostaglandin Thromboxane Res. 1976;1:99–103. [PubMed] [Google Scholar]
  42. Dembińska-Kieć A., Grodzińska L., Piotrowicz J. The influence of indomethacin on the prostaglandins synthetase system in rat tissues in vivo. Pol J Pharmacol Pharm. 1974 Jan-Apr;26(1):79–82. [PubMed] [Google Scholar]
  43. Didisheim P., Fuster V. Actions and clinical status of platelet-suppressive agents. Semin Hematol. 1978 Jan;15(1):55–72. [PubMed] [Google Scholar]
  44. Elliott R. B., Starling M. B., Neutze J. M. Medical manipulation of the ductus arteriosus. Lancet. 1975 Jan 18;1(7899):140–142. doi: 10.1016/s0140-6736(75)91432-4. [DOI] [PubMed] [Google Scholar]
  45. Elwood P. C., Cochrane A. L., Burr M. L., Sweetnam P. M., Williams G., Welsby E., Hughes S. J., Renton R. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974 Mar 9;1(5905):436–440. doi: 10.1136/bmj.1.5905.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ferreira S. H., Moncada S., Vane J. R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol. 1971 Jun 23;231(25):237–239. doi: 10.1038/newbio231237a0. [DOI] [PubMed] [Google Scholar]
  47. Fichman M. P., Telfer N., Zia P., Speckart P., Golub M., Rude R. Role of prostaglandins in the pathogenesis of Bartter's syndrome. Am J Med. 1976 May 31;60(6):785–797. doi: 10.1016/0002-9343(76)90892-5. [DOI] [PubMed] [Google Scholar]
  48. Fields W. S., Lemak N. A., Frankowski R. F., Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Stroke. 1977 May-Jun;8(3):301–314. doi: 10.1161/01.str.8.3.301. [DOI] [PubMed] [Google Scholar]
  49. Flower R. J., Cheung H. S., Cushman D. W. Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle. Prostaglandins. 1973 Sep;4(3):325–341. doi: 10.1016/0090-6980(73)90020-8. [DOI] [PubMed] [Google Scholar]
  50. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  51. Flower R. J., Vane J. R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972 Dec 15;240(5381):410–411. doi: 10.1038/240410a0. [DOI] [PubMed] [Google Scholar]
  52. Friedman W. F., Hirschklau M. J., Printz M. P., Pitlick P. T., Kirkpatrick S. E. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976 Sep 2;295(10):526–529. doi: 10.1056/NEJM197609022951003. [DOI] [PubMed] [Google Scholar]
  53. Friedman W. F. Pharmacologic treatment of patent ductus arteriosus. Adv Cardiol. 1979;26:65–75. doi: 10.1159/000402390. [DOI] [PubMed] [Google Scholar]
  54. Fuchs A. R. Myometrial response to prostaglandins enhanced by progesterone. Am J Obstet Gynecol. 1974 Apr 15;118(8):1093–1098. doi: 10.1016/0002-9378(74)90688-7. [DOI] [PubMed] [Google Scholar]
  55. Fuchs A. R., Smitasiri Y., Chantharaksri U. The effect of indomethacin on uterine contractility and luteal regression in pregnant rats at term. J Reprod Fertil. 1976 Nov;48(2):331–340. doi: 10.1530/jrf.0.0480331. [DOI] [PubMed] [Google Scholar]
  56. Galasko C. S., Bennett A. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins. Nature. 1976 Oct 7;263(5577):508–510. doi: 10.1038/263508a0. [DOI] [PubMed] [Google Scholar]
  57. Gardner J. D., Simopoulos A. P., Lapey A., Shibolet S. Altered membrane sodium transport in Bartter's syndrome. J Clin Invest. 1972 Jun;51(6):1565–1571. doi: 10.1172/JCI106953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Garrioch D. B. The effect of indomethacin on spontaneous activity in the isolated human myometrium and on the response to oxytocin and prostaglandin. Br J Obstet Gynaecol. 1978 Jan;85(1):47–52. doi: 10.1111/j.1471-0528.1978.tb15825.x. [DOI] [PubMed] [Google Scholar]
  59. Gasic G. J., Gasic T. B., Galanti N., Johnson T., Murphy S. Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer. 1973 May;11(3):704–718. doi: 10.1002/ijc.2910110322. [DOI] [PubMed] [Google Scholar]
  60. Gasic G. J., Gasic T. B., Stewart C. C. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968 Sep;61(1):46–52. doi: 10.1073/pnas.61.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Genton E., Gent M., Hirsh J., Harker L. A. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts). N Engl J Med. 1975 Dec 4;293(23):1174–1178. doi: 10.1056/NEJM197512042932305. [DOI] [PubMed] [Google Scholar]
  62. Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. doi: 10.1056/NEJM197711032971802. [DOI] [PubMed] [Google Scholar]
  63. Gordon D., Bray M. A., Morley J. Control of lymphokine secretion by prostaglandins. Nature. 1976 Jul 29;262(5567):401–402. doi: 10.1038/262401a0. [DOI] [PubMed] [Google Scholar]
  64. Gordon J. L., Pearson J. D. Effects of sulphinpyrazone and aspirin on prostaglandin I2 (prostacyclin) synthesis by endothelial cells. Br J Pharmacol. 1978 Dec;64(4):481–483. doi: 10.1111/j.1476-5381.1978.tb17308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Gorman R. R., Bunting S., Miller O. V. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins. 1977 Mar;13(3):377–388. doi: 10.1016/0090-6980(77)90018-1. [DOI] [PubMed] [Google Scholar]
  66. Greenway F. L., Swerdloff R. S. The effect of aspirin (prostaglandin synthetase inhibitor) on ovulation. Fertil Steril. 1978 Sep;30(3):364–365. doi: 10.1016/s0015-0282(16)43527-2. [DOI] [PubMed] [Google Scholar]
  67. Gruber C. M., Jr, Ridolfo A. S., Nickander R., Mikulaschek W. M. Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation. Clin Pharmacol Ther. 1972 Jan-Feb;13(1):109–113. doi: 10.1002/cpt1972131109. [DOI] [PubMed] [Google Scholar]
  68. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
  69. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Harker L. A., Slichter S. J. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med. 1970 Dec 10;283(24):1302–1305. doi: 10.1056/NEJM197012102832402. [DOI] [PubMed] [Google Scholar]
  71. Harris M., Jenkins M. V., Bennett A., Hird V. M., Wills M. R. Letter: Leucocytes, bone resorption, and prostaglandins. Lancet. 1974 Feb 16;1(7851):265–265. doi: 10.1016/s0140-6736(74)92570-7. [DOI] [PubMed] [Google Scholar]
  72. Harris M., Jenkins M. V., Bennett A., Wills M. R. Prostaglandin production and bone resorption by dental cysts. Nature. 1973 Sep 28;245(5422):213–215. doi: 10.1038/245213a0. [DOI] [PubMed] [Google Scholar]
  73. Heath H., Brigden W. D., Canever J. V., Pollock J., Hunter P. R., Kelsey J., Bloom A. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia. 1971 Oct;7(5):308–315. doi: 10.1007/BF01219463. [DOI] [PubMed] [Google Scholar]
  74. Hedqvist P. Prostaglandin E compounds and sympathetic neuromuscular transmission. Ann N Y Acad Sci. 1971 Apr 30;180:410–415. doi: 10.1111/j.1749-6632.1971.tb53208.x. [DOI] [PubMed] [Google Scholar]
  75. Heymann M. A., Rudolph A. M. Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero. Circ Res. 1976 May;38(5):418–422. doi: 10.1161/01.res.38.5.418. [DOI] [PubMed] [Google Scholar]
  76. Heymann M. A., Rudolph A. M., Silverman N. H. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976 Sep 2;295(10):530–533. doi: 10.1056/NEJM197609022951004. [DOI] [PubMed] [Google Scholar]
  77. Horton E. W., Poyser N. L. Elongation of oestrous cycle in the guinea-pig following subcutaneous or intra-uterine administration of indomethacin. Br J Pharmacol. 1973 Sep;49:98–105. [PMC free article] [PubMed] [Google Scholar]
  78. Horton J. E., Raisz L. G., Simmons H. A., Oppenheim J. J., Mergenhagen S. E. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science. 1972 Sep 1;177(4051):793–795. doi: 10.1126/science.177.4051.793. [DOI] [PubMed] [Google Scholar]
  79. Jaffe B. M. Prostaglandins and cancer: an update. Prostaglandins. 1974 Jun 25;6(6):453–461. doi: 10.1016/s0090-6980(74)80055-9. [DOI] [PubMed] [Google Scholar]
  80. Janbu T., Løkken P., Nesheim B. I. Effect of acetylsalicylic acid, paracetamol, and placebo on pain and blood loss in dysmenorrhoeic women. Eur J Clin Pharmacol. 1978 Dec 18;14(6):413–416. doi: 10.1007/BF00716382. [DOI] [PubMed] [Google Scholar]
  81. Kaegi A., Pineo G. F., Shimizu A., Trivedi H., Hirsh J., Gent M. Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone. N Engl J Med. 1974 Feb 7;290(6):304–306. doi: 10.1056/NEJM197402072900604. [DOI] [PubMed] [Google Scholar]
  82. Kapadia L., Elder M. G. Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study. Lancet. 1978 Feb 18;1(8060):348–350. doi: 10.1016/s0140-6736(78)91078-4. [DOI] [PubMed] [Google Scholar]
  83. Kelton J. G., Hirsh J., Carter C. J., Buchanan M. R. Sex differences in the antithrombotic effects of aspirin. Blood. 1978 Nov;52(5):1073–1076. [PubMed] [Google Scholar]
  84. Kirschenbaum M. A., White N., Stein J. H., Ferris T. F. Redistribution of renal cortical blood flow during inhibition of prostaglandin synthesis. Am J Physiol. 1974 Oct;227(4):801–805. doi: 10.1152/ajplegacy.1974.227.4.801. [DOI] [PubMed] [Google Scholar]
  85. Kirton K. T., Kimball F. A., Porteus S. E. Reproductive physiology: prostaglandin-associated events. Adv Prostaglandin Thromboxane Res. 1976;2:621–625. [PubMed] [Google Scholar]
  86. Klein D. C., Raisz L. G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970 Jun;86(6):1436–1440. doi: 10.1210/endo-86-6-1436. [DOI] [PubMed] [Google Scholar]
  87. Ku E. C., Signor C., Eakins E. Antiinflammatory agents and inhibition of ocular prostaglandin synthetase. Adv Prostaglandin Thromboxane Res. 1976;2:819–823. [PubMed] [Google Scholar]
  88. Kwaan H. C., Colwell J. A., Cruz S., Suwanwela N., Dobbie J. G. Increased platelet aggregation in diabetes mellitus. J Lab Clin Med. 1972 Aug;80(2):236–246. [PubMed] [Google Scholar]
  89. Leader A., Bygdeman M., Eneroth P., Martin J. N., Jr, Wiqvist N. The effect of infusions with two analogues of prostaglandin F2alpha on corpus luteum function. Adv Prostaglandin Thromboxane Res. 1976;2:679–685. [PubMed] [Google Scholar]
  90. Levin D. L., Mills L. J., Parkey M., Garriott J., Campbell W. Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant ewe. J Pediatr. 1979 Apr;94(4):647–650. doi: 10.1016/s0022-3476(79)80043-8. [DOI] [PubMed] [Google Scholar]
  91. Lindsey H. E., Wyllie J. H. Release of prostaglandins from embolized lungs. Br J Surg. 1970 Oct;57(10):738–741. doi: 10.1002/bjs.1800571011. [DOI] [PubMed] [Google Scholar]
  92. Lundström V. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors--a promising therapeutic alternative. Acta Obstet Gynecol Scand. 1978;57(5):421–428. doi: 10.3109/00016347809156523. [DOI] [PubMed] [Google Scholar]
  93. MURPHY E. A., ROWSELL H. C., DOWNIE H. G., ROBINSON G. A., MUSTARD J. F. Encrustation and atherosclerosis: the analogy between early in vivo lesions and deposits which occur in extracorporeal circulations. Can Med Assoc J. 1962 Aug 11;87:259–274. [PMC free article] [PubMed] [Google Scholar]
  94. Mackenzie I. Z., Hillier K., Embrey M. P. Intrauterine prostaglandin E2 as an postconceptional abortifacient. Adv Prostaglandin Thromboxane Res. 1976;2:687–691. [PubMed] [Google Scholar]
  95. Marx J. L. Dysmenorrhea: basic research leads to a rational therapy. Science. 1979 Jul 13;205(4402):175–176. doi: 10.1126/science.109921. [DOI] [PubMed] [Google Scholar]
  96. Mathur G. P., Gandhi V. M. Prostaglandin in human and albino rat skin. J Invest Dermatol. 1972 May;58(5):291–295. doi: 10.1111/1523-1747.ep12540305. [DOI] [PubMed] [Google Scholar]
  97. Mennie A. T., Dalley V. Aspirin in radiation-induced diarrhoea. Lancet. 1973 May 19;1(7812):1131–1131. doi: 10.1016/s0140-6736(73)90451-0. [DOI] [PubMed] [Google Scholar]
  98. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  99. Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979 May 17;300(20):1142–1147. doi: 10.1056/NEJM197905173002006. [DOI] [PubMed] [Google Scholar]
  100. Moncada S., Vane J. R. Mode of action of aspirin-like drugs. Adv Intern Med. 1979;24:1–22. [PubMed] [Google Scholar]
  101. Morley J. Mechanism of action of aspirin in inflammation. Proc R Soc Med. 1977;70 (Suppl 7):32–34. [PMC free article] [PubMed] [Google Scholar]
  102. Mundy G. R., Luben R. A., Raisz L. G., Oppenheim J. J., Buell D. N. Bone-resorbing activity in supernatants from lymphoid cell lines. N Engl J Med. 1974 Apr 18;290(16):867–871. doi: 10.1056/NEJM197404182901601. [DOI] [PubMed] [Google Scholar]
  103. Mustard J. F., Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev. 1970 Jun;22(2):97–187. [PubMed] [Google Scholar]
  104. Norby L., Flamenbaum W., Lentz R., Ramwell P. Prostaglandins and aspirin therapy in Bartter's syndrome. Lancet. 1976 Sep 18;2(7986):604–606. doi: 10.1016/s0140-6736(76)90669-3. [DOI] [PubMed] [Google Scholar]
  105. O'Grady J., Moncada S. Aspirin: A paradoxical effect on bleeding-time. Lancet. 1978 Oct 7;2(8093):780–780. doi: 10.1016/s0140-6736(78)92661-2. [DOI] [PubMed] [Google Scholar]
  106. O'Malley C. B., Ward J. D., Timperley W. R., Porter N. R., Preston F. E. Platelet abnormalities in diabetic peripheral neuropathy. Lancet. 1975 Dec 27;2(7948):1274–1276. doi: 10.1016/s0140-6736(75)90610-8. [DOI] [PubMed] [Google Scholar]
  107. O'brien J. R. Platelet aggregation: Part I Some effects of the adenosine phosphates, thrombin, and cocaine upon platelet adhesiveness. J Clin Pathol. 1962 Sep;15(5):446–452. doi: 10.1136/jcp.15.5.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Orczyk G. P., Behrman H. R. Ovulation blockade by aspirin or indomethacin--in vivo evidence for a role of prostaglandin in gonadotrophin secretion. Prostaglandins. 1972 Jan;1(1):3–20. doi: 10.1016/0090-6980(72)90061-5. [DOI] [PubMed] [Google Scholar]
  109. PICKLES V. R., HALL W. J., BEST F. A., SMITH G. N. PROSTAGLANDINS IN ENDOMETRIUM AND MENSTRUAL FLUID FROM NORMAL AND DYSMENORRHOEIC SUBJECTS. J Obstet Gynaecol Br Commonw. 1965 Apr;72:185–192. doi: 10.1111/j.1471-0528.1965.tb01415.x. [DOI] [PubMed] [Google Scholar]
  110. Palmer M. A., Piper P. J., Vane J. R. Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs. Br J Pharmacol. 1973 Oct;49(2):226–242. doi: 10.1111/j.1476-5381.1973.tb08368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Panush R. S., Anthony C. R. Effects of acetylsalicylic acid on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine. Clin Exp Immunol. 1976 Jan;23(1):114–125. [PMC free article] [PubMed] [Google Scholar]
  112. Paulus H. E., Whitehouse M. W. Nonsteroid anti-inflammatory agents. Annu Rev Pharmacol. 1973;13:107–125. doi: 10.1146/annurev.pa.13.040173.000543. [DOI] [PubMed] [Google Scholar]
  113. Pelus L. M., Strausser H. R. Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice. Int J Cancer. 1976 Nov 15;18(5):653–660. doi: 10.1002/ijc.2910180514. [DOI] [PubMed] [Google Scholar]
  114. Peterson J., Amare M., Henry J. E., Bone R. C. Splenectomy and antiplatelet agents in thrombotic thrombocytopenic purpura. Am J Med Sci. 1979 Jan-Feb;277(1):75–89. doi: 10.1097/00000441-197901000-00009. [DOI] [PubMed] [Google Scholar]
  115. Pharriss B. B., Wyngarden L. J. The effect of prostaglandin F 2alpha on the progestogen content of ovaries from pseudopregnant rats. Proc Soc Exp Biol Med. 1969 Jan;130(1):92–94. doi: 10.3181/00379727-130-33495. [DOI] [PubMed] [Google Scholar]
  116. Pick R., Chediak J., Glick G. Aspirin inhibits development of coronary atherosclerosis in cynomolgus monkeys (Macaca fascicularis) fed an atherogenic diet. J Clin Invest. 1979 Jan;63(1):158–162. doi: 10.1172/JCI109272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Plummer N. A., Hensby C. N., Black A. K., Greaves M. W. Prostaglandin activity in sustained inflammation of human skin before and after aspirin. Clin Sci Mol Med. 1977 Jun;52(6):615–620. doi: 10.1042/cs0520615. [DOI] [PubMed] [Google Scholar]
  118. Potter M. R., Moore M. The effect of adherent and phagocytic cells on human lymphocyte PHA responsiveness. Clin Exp Immunol. 1977 Jan;27(1):159–164. [PMC free article] [PubMed] [Google Scholar]
  119. Powles T. J., Clark S. A., Easty D. M., Easty G. C., Neville A. M. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer. 1973 Oct;28(4):316–321. doi: 10.1038/bjc.1973.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Poyser N. L. Prostaglandin F2alpha is the uterine luteolytic hormone in the guinea pig: the evidence reviewed. Adv Prostaglandin Thromboxane Res. 1976;2:633–643. [PubMed] [Google Scholar]
  121. Preston F. E., Emmanuel I. G., Winfield D. A., Malia R. G. Essential thrombocythaemia and peripheral gangrene. Br Med J. 1974 Aug 31;3(5930):548–552. doi: 10.1136/bmj.3.5930.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Pulkkinen M. O., Csapo A. I. The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients. Prostaglandins. 1978 Jun;15(6):1055–1062. doi: 10.1016/0090-6980(78)90048-5. [DOI] [PubMed] [Google Scholar]
  123. Pulkkinen M. O., Henzl M. R., Csapo A. I. The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine "jet-washings" in dysmenorrheic women. Prostaglandins. 1978 Mar;15(3):543–550. doi: 10.1016/0090-6980(78)90138-7. [DOI] [PubMed] [Google Scholar]
  124. Reiss U., Atad J., Rubinstein I., Zuckerman H. The effect of indomethacin in labour at term. Int J Gynaecol Obstet. 1976;14(4):369–374. doi: 10.1002/j.1879-3479.1976.tb00629.x. [DOI] [PubMed] [Google Scholar]
  125. Roberts J. S., Carlson J. C., McCracken J. A. Prostaglandin F2alpha production by the brain and its role in LH secretion. Adv Prostaglandin Thromboxane Res. 1976;2:609–619. [PubMed] [Google Scholar]
  126. Robinson D. R., Tashjian A. H., Jr, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest. 1975 Nov;56(5):1181–1188. doi: 10.1172/JCI108195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Robson J. M., Schild H. O. Response of the cat's uterus to the hormones of the posterior pituitary lobe. J Physiol. 1938 Feb 16;92(1):1–8. doi: 10.1113/jphysiol.1938.sp003578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Romero J. C., Dunlap C. L., Strong C. G. The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system. J Clin Invest. 1976 Aug;58(2):282–288. doi: 10.1172/JCI108470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Rosenberg F. J., Gimber-Phillips P. E., Groblewski G. E., Davison C., Phillips D. K., Goralnick S. J., Cahill E. D. Acetylsalicylic acid: inhibition of platelet aggregation in the rabbit. J Pharmacol Exp Ther. 1971 Nov;179(2):410–418. [PubMed] [Google Scholar]
  130. Roth G. J., Stanford N., Majerus P. W. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3073–3076. doi: 10.1073/pnas.72.8.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Roux J. F., Mofid M., Moss P. L., Dmytrus K. C. Effect of elective induction of labor with prostaglandins F2alpha and E2 and oxytocin on uterine contraction and relaxation. Am J Obstet Gynecol. 1977 Apr 1;127(7):718–722. doi: 10.1016/0002-9378(77)90245-9. [DOI] [PubMed] [Google Scholar]
  132. Rådegran K., McAslan C. Circulatory and ventilatory effects of induced platelet aggregation and their inhibition by acetylsalicylic acid. Acta Anaesthesiol Scand. 1972;16(2):76–84. doi: 10.1111/j.1399-6576.1972.tb00573.x. [DOI] [PubMed] [Google Scholar]
  133. Sandok B. A., Furlan A. J., Whisnant J. P., Sundt T. M., Jr Guidelines for the management of transient ischemic attacks. Mayo Clin Proc. 1978 Oct;53(10):665–674. [PubMed] [Google Scholar]
  134. Smith I. D., Temple D. M., Shearman R. P. The antagonism by anti-inflammatory analgesics of prostaglandin f 2 alpha-induced contractions of human and rabbit myometrium in vitro. Prostaglandins. 1975 Jul;10(1):41–57. doi: 10.1016/0090-6980(75)90092-1. [DOI] [PubMed] [Google Scholar]
  135. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  136. Smith M. J., Dawkins P. D. Salicylate and enzymes. J Pharm Pharmacol. 1971 Oct;23(10):729–744. doi: 10.1111/j.2042-7158.1971.tb08598.x. [DOI] [PubMed] [Google Scholar]
  137. Snyder D. S., Eaglstein W. H. Topical indomethacin and sunburn. Br J Dermatol. 1974 Jan;90(1):91–93. [PubMed] [Google Scholar]
  138. Snyder D. S. Effect of topical indomethacin on UVR-induced redness and prostaglandin E levels in sunburned guinea pig skin. Prostaglandins. 1976 Apr;11(4):631–643. doi: 10.1016/0090-6980(76)90066-6. [DOI] [PubMed] [Google Scholar]
  139. Solez K., Fox J. A., Miller M., Heptinstall R. H. Effects of indomethacin on renal inner medullary plasma flow. Prostaglandins. 1974 Jul 25;7(2):91–98. doi: 10.1016/0090-6980(74)90126-9. [DOI] [PubMed] [Google Scholar]
  140. Solomon R. J., Brown R. S. Bartter's syndrome. New insights into pathogenesis and treatment. Am J Med. 1975 Oct;59(4):575–583. doi: 10.1016/0002-9343(75)90265-x. [DOI] [PubMed] [Google Scholar]
  141. Sykes J. A., Moddox I. S. Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds. Nat New Biol. 1972 May 10;237(71):59–61. doi: 10.1038/newbio237059a0. [DOI] [PubMed] [Google Scholar]
  142. Tashjian A. H., Jr, Voelkel E. F., Goldhaber P., Levine L. Prostaglandins, calcium metabolism and cancer. Fed Proc. 1974 Jan;33(1):81–86. [PubMed] [Google Scholar]
  143. Tateson J. E., Moncada S., Vane J. R. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins. 1977 Mar;13(3):389–397. doi: 10.1016/0090-6980(77)90019-3. [DOI] [PubMed] [Google Scholar]
  144. Trygstad C. W., Mangos J. A., Bloodworth J. M., Jr, Lobeck C. C. A sibship with Bartter's syndrome: failure of total adrenalectomy to correct the potassium wasting. Pediatrics. 1969 Aug;44(2):234–242. [PubMed] [Google Scholar]
  145. Tucker A., Weir E. K., Reeves J. T., Grover R. F. Pulmonary microembolism: attenuated pulmonary vasoconstriction with prostaglandin inhibitors and antihistamines. Prostaglandins. 1976 Jan;11(1):31–41. doi: 10.1016/0090-6980(76)90170-2. [DOI] [PubMed] [Google Scholar]
  146. Vaage J., Piper P. J. The release of prostaglandin-like substances during platelet aggregation and pulmonary microembolism. Acta Physiol Scand. 1975 May;94(1):8–13. doi: 10.1111/j.1748-1716.1975.tb05856.x. [DOI] [PubMed] [Google Scholar]
  147. Van Boxel J. A., Paget S. A. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med. 1975 Sep 11;293(11):517–520. doi: 10.1056/NEJM197509112931101. [DOI] [PubMed] [Google Scholar]
  148. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  149. Vane J. R., Williams K. I. The contribution of prostaglandin production to contractions of the isolated uterus of the rat. Br J Pharmacol. 1973 Aug;48(4):629–639. doi: 10.1111/j.1476-5381.1973.tb08250.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Vargaftig B. B., Lefort J. Acute hypotension due to carrageenan, arachidonic acid and slow reacting substance C in the rabbit: role of platelets and nature of pharmacological antagonism. Eur J Pharmacol. 1977 May 15;43(2):125–141. doi: 10.1016/0014-2999(77)90125-x. [DOI] [PubMed] [Google Scholar]
  151. Verberckmoes R., van Damme B B., Clement J., Amery A., Michielsen P. Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. Kidney Int. 1976 Mar;9(3):302–307. doi: 10.1038/ki.1976.33. [DOI] [PubMed] [Google Scholar]
  152. WILHELMI G., DOMENJOZ R. Vergleichende Untersuchungen über die Wirkung von Pyrazolen und Antihistaminen bei verschiedenen Arten der Experimentellen Entzündung. Arch Int Pharmacodyn Ther. 1951 Jan;85(1-2):129–143. [PubMed] [Google Scholar]
  153. Waltman R., Tricomi V., Palav A. B. Mid-trimester hypertonic saline--induced abortion: effect of indomethacin on induction-abortion time. Am J Obstet Gynecol. 1972 Nov 15;114(6):829–831. doi: 10.1016/0002-9378(72)90910-6. [DOI] [PubMed] [Google Scholar]
  154. Webb D. R., Jr, Jamieson T. Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action. Cell Immunol. 1976 Jun 1;24(1):45–57. doi: 10.1016/0008-8749(76)90130-1. [DOI] [PubMed] [Google Scholar]
  155. Weir E. K., Grover R. F. The role of endogenous prostaglandins in the pulmonary circulation. Anesthesiology. 1978 Mar;48(3):201–212. doi: 10.1097/00000542-197803000-00008. [DOI] [PubMed] [Google Scholar]
  156. Weiss H. J., Aledort L. M., Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest. 1968 Sep;47(9):2169–2180. doi: 10.1172/JCI105903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Wentz A. C., Jones G. S. Transient luteolytic effect of prostaglandin F2alpha in the human. Obstet Gynecol. 1973 Aug;42(2):172–181. [PubMed] [Google Scholar]
  158. Whittaker N., Bunting S., Salmon J., Moncada S., Vane J. R., Johnson R. A., Morton D. R., Kinner J. H., Gorman R. R., McGuire J. C. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins. 1976 Dec;12(6):915–928. doi: 10.1016/0090-6980(76)90126-x. [DOI] [PubMed] [Google Scholar]
  159. Williams K. I., El-Tahir K. E., Marcinkiewicz E. Dual actions of prostacyclin (PGI2) on the rat pregnant uterus. Prostaglandins. 1979 May;17(5):667–672. doi: 10.1016/s0090-6980(79)80039-8. [DOI] [PubMed] [Google Scholar]
  160. Wu K. K., Hoak J. C. Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Thromb Haemost. 1976 Jun 30;35(3):702–711. [PubMed] [Google Scholar]
  161. Ying C. Y., Parrish J. A., Pathak M. A. Additive erythemogenic effects of middle-(280-320 nm) and long-(320-400 nm) wave ultraviolet light. J Invest Dermatol. 1974 Sep;63(3):273–278. doi: 10.1111/1523-1747.ep12680141. [DOI] [PubMed] [Google Scholar]
  162. Ylikorkala O., Kauppila A., Puolakka J. Naproxen suppositories in primary dysmenorrhoea. Lancet. 1979 Feb 3;1(8110):278–278. doi: 10.1016/s0140-6736(79)90811-0. [DOI] [PubMed] [Google Scholar]
  163. Zeluff G. W., Natelson E. A., Jackson D. Thrombocytopenic purpura--idiopathic and thrombotic. Heart Lung. 1978 Mar-Apr;7(2):327–333. [PubMed] [Google Scholar]
  164. Zucker M. B., Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med. 1968 Feb;127(2):547–551. doi: 10.3181/00379727-127-32737. [DOI] [PubMed] [Google Scholar]
  165. Zuckerman H., Reiss U., Atad J., Lampert I., Ezra S. B., Sklan D. The effect of indomethacin on plasma levels of prostaglandin F2alpha in women in labour. Br J Obstet Gynaecol. 1977 May;84(5):339–343. doi: 10.1111/j.1471-0528.1977.tb12595.x. [DOI] [PubMed] [Google Scholar]
  166. Zuckerman H., Reiss U., Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol. 1974 Dec;44(6):787–792. [PubMed] [Google Scholar]
  167. ten Cate J. W., Vos J., Oosterhuis H., Prenger D., Jenkins C. S. Spontaneous platelet aggregation in cerebrovascular disease. Thromb Haemost. 1978 Feb 28;39(1):223–229. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES